A state-of-the-art, innovative chronic pain research and treatment facility based in Sulmona at San Raffaele Nursing Home.
Chronic pain represents the most prevalent disease in the Italian population.
The “Techno-Algos Center,” a project resulting from the collaboration and synergy of purpose between the ISAL Foundation and the San Raffaele Sulmona Nursing Home, was presented in Sulmona in the Conference Room of the Diocesan Pastoral Center.
This is a new state-of-the-art facility for the research and treatment of complex chronic pain resulting from neuromyellesion, soon to be activated at the San Raffaele Sulmona Treatment Center.
Chronic pain is the most prevalent disease among the Italian population. According to data from the Ministry of Health, more than 13 million of our countrymen suffer from it, and 4 million of them fail to get the treatment they would need to alleviate their daily suffering.
It is precisely the latter, those who are precisely suffering from chronic complex pain, for whom a strong investment in scientific research is needed, so that adequate treatments can be found to ensure that this category of sufferers, too, can receive the relief capable of restoring serenity to their lives.
Within the various forms of complex chronic pain is that present in individuals who have severe neuromyelolal damage, a pain of a very special kind that constitutes a heavy exacerbation of suffering over and above that in itself produced by the motor impairment and which, in many cases, is considered by the sufferers themselves to be the most important problem with which to deal on a daily basis.
Based on this knowledge the Isal Foundation and IRCCS San Raffaele Roma have decided to establish in Sulmona, within the San Raffaele Nursing Home, the “Techno-Algos Center, a research and treatment center that has the ambition of charting a new course in the care of patients undergoing rehabilitation treatment following neuromedullary injury.
An ambition that is based on the recognized experience and expertise of the two institutions in specific fields of research and is fueled by the well-established and fruitful relationship of collaboration and synergy of purpose that has now existed between them for many years.
In addition, in an effort to disseminate the research results and experiences gained in the implementation of the project starting in Sulmona, a mighty boost will be given to the educational-training activities of health care personnel working in the field covered by this intervention by means of the “European School of Advanced Training in Pain Therapy” of the Isal Foundation, which will be relocated to the San Raffaele Sulmona Nursing Home for the occasion.
With the birth of the “Tecno-Algos Center” in Sulmona, not only an innovative research and treatment facility for neuromyelolysis patients comes to life, but also a broader project that can represent a great overall development opportunity for an area, the Peligna Valley in central Abruzzo, that aspires to its different relocation in the regional socioeconomic landscape.
“The forthcoming activation of the ‘Techno-Algos Center’ at the San Raffaele Nursing Home in Sulmona plastically represents the value of a long and fruitful cooperative relationship between the two institutions in the field of scientific research. It is, also, the launch of an innovative project aimed at transferring the results of the research itself into the concreteness of clinical practice and care activities. – stated Dr. Gianvincenzo D’Andrea, vice president of the Isal Foundation. – It starts, today, with a strong commitment in the area of chronic complex neuro/myelogenous pain to pursue, later, other avenues in the field of pain that is difficult to treat today. A choice motivated by the decision to work innovatively for the benefit of chronic pain patients who, 10 years after the approval of Law 38 / 2010, still do not see their right to certain and effective treatment fully recognized. In the Techno-Algos Center, the Isal Foundation intends to invest, and will invest, the best it has at its disposal in terms of technology and human resources to achieve the goal of providing the best care pathways for those who live their daily lives disrupted by the suffering produced by chronic pain. We do this knowing that the sooner we achieve the desired results, the more unnecessary suffering we can eliminate.”
“Just these days, data were extrapolated from a study conducted over the past six months that aimed to assess changes in the clinical conditions of chronic-phase myelolysis patients who were not eligible for inpatient follow-up treatment during the lockdown period,” says Dr. K. Giorgio Felzani, Chief of the Spinal Unit San Raffaele Sulmona Nursing Home. It was found that, among the clinical aspects taken into consideration related to the most frequent reasons for returning to the Spinal Unit, 85.6 percent of respondents reported that pain intensified significantly,” the Chief concluded.
“Chronic pain is one of the health, social and economic emergencies of this century that involves not only patients and caregivers, but the entire Health System,” says the Prof. Massimo Fini, scientific director of IRCCS San Raffaele Rome. In March 2010, Law 38 was enacted to ensure patient access to palliative care and pain therapy as part of the essential levels of care, which is still unimplemented in some regional settings. Hence the idea of combining the know-how and expertise of Isal and San Raffaele with the aim of developing a unique, cutting-edge and replicable model of care in order to ensure health needs, equity in access to care, quality of care and its appropriateness with regard to specific needs,” Professor concludes.
A state-of-the-art, innovative chronic pain research and treatment facility based in Sulmona at San Raffaele Nursing Home.
Chronic pain represents the most prevalent disease in the Italian population.
The “Techno-Algos Center,” a project resulting from the collaboration and synergy of purpose between the ISAL Foundation and the San Raffaele Sulmona Nursing Home, was presented in Sulmona in the Conference Room of the Diocesan Pastoral Center.
This is a new state-of-the-art facility for the research and treatment of complex chronic pain resulting from neuromyellesion, soon to be activated at the San Raffaele Sulmona Treatment Center.
Chronic pain is the most prevalent disease among the Italian population. According to data from the Ministry of Health, more than 13 million of our countrymen suffer from it, and 4 million of them fail to get the treatment they would need to alleviate their daily suffering.
It is precisely the latter, those who are precisely suffering from chronic complex pain, for whom a strong investment in scientific research is needed, so that adequate treatments can be found to ensure that this category of sufferers, too, can receive the relief capable of restoring serenity to their lives.
Within the various forms of complex chronic pain is that present in individuals who have severe neuromyelolal damage, a pain of a very special kind that constitutes a heavy exacerbation of suffering over and above that in itself produced by the motor impairment and which, in many cases, is considered by the sufferers themselves to be the most important problem with which to deal on a daily basis.
Based on this knowledge the Isal Foundation and IRCCS San Raffaele Roma have decided to establish in Sulmona, within the San Raffaele Nursing Home, the “Techno-Algos Center, a research and treatment center that has the ambition of charting a new course in the care of patients undergoing rehabilitation treatment following neuromedullary injury.
An ambition that is based on the recognized experience and expertise of the two institutions in specific fields of research and is fueled by the well-established and fruitful relationship of collaboration and synergy of purpose that has now existed between them for many years.
In addition, in an effort to disseminate the research results and experiences gained in the implementation of the project starting in Sulmona, a mighty boost will be given to the educational-training activities of health care personnel working in the field covered by this intervention by means of the “European School of Advanced Training in Pain Therapy” of the Isal Foundation, which will be relocated to the San Raffaele Sulmona Nursing Home for the occasion.
With the birth of the “Tecno-Algos Center” in Sulmona, not only an innovative research and treatment facility for neuromyelolysis patients comes to life, but also a broader project that can represent a great overall development opportunity for an area, the Peligna Valley in central Abruzzo, that aspires to its different relocation in the regional socioeconomic landscape.
“The forthcoming activation of the ‘Techno-Algos Center’ at the San Raffaele Nursing Home in Sulmona plastically represents the value of a long and fruitful cooperative relationship between the two institutions in the field of scientific research. It is, also, the launch of an innovative project aimed at transferring the results of the research itself into the concreteness of clinical practice and care activities. – stated Dr. Gianvincenzo D’Andrea, vice president of the Isal Foundation. – It starts, today, with a strong commitment in the area of chronic complex neuro/myelogenous pain to pursue, later, other avenues in the field of pain that is difficult to treat today. A choice motivated by the decision to work innovatively for the benefit of chronic pain patients who, 10 years after the approval of Law 38 / 2010, still do not see their right to certain and effective treatment fully recognized. In the Techno-Algos Center, the Isal Foundation intends to invest, and will invest, the best it has at its disposal in terms of technology and human resources to achieve the goal of providing the best care pathways for those who live their daily lives disrupted by the suffering produced by chronic pain. We do this knowing that the sooner we achieve the desired results, the more unnecessary suffering we can eliminate.”
“Just these days, data were extrapolated from a study conducted over the past six months that aimed to assess changes in the clinical conditions of chronic-phase myelolysis patients who were not eligible for inpatient follow-up treatment during the lockdown period,” says Dr. K. Giorgio Felzani, Chief of the Spinal Unit San Raffaele Sulmona Nursing Home. It was found that, among the clinical aspects taken into consideration related to the most frequent reasons for returning to the Spinal Unit, 85.6 percent of respondents reported that pain intensified significantly,” the Chief concluded.
“Chronic pain is one of the health, social and economic emergencies of this century that involves not only patients and caregivers, but the entire Health System,” says the Prof. Massimo Fini, scientific director of IRCCS San Raffaele Rome. In March 2010, Law 38 was enacted to ensure patient access to palliative care and pain therapy as part of the essential levels of care, which is still unimplemented in some regional settings. Hence the idea of combining the know-how and expertise of Isal and San Raffaele with the aim of developing a unique, cutting-edge and replicable model of care in order to ensure health needs, equity in access to care, quality of care and its appropriateness with regard to specific needs,” Professor concludes.
